Mild ovarian stimulation using the aromatase inhibitor letrozole (LTZ) is a good stimulation protocol for to obtain euploid blastocysts for advanced maternal age women.
Authors:
- Koji NakagawaKNKoji Nakagawa
- Takashi HorikawaTHTakashi Horikawa
- Kesuke ShiobaraKSKesuke Shiobara
- Shunsuke IshiyamaSIShunsuke Ishiyama
- Hisayo KataokaHKHisayo Kataoka
- Katsuki NakaoKNKatsuki Nakao
- Yuko OjiroYOYuko Ojiro
- Keiji KuodaKKKeiji Kuoda
- Satoru TakamizawaSTSatoru Takamizawa
- Rikikazu SugiyamaRSRikikazu Sugiyama
Preprint
- 13 March 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Purpose: Mild ovarian stimulation (MOS) is an effective form of assisted reproductive technology (ART) for advanced maternal age (AMA) women. Taking either clomiphene (CC) or letrozole (LTZ) with MOS reduces the amount of gonadotropin that must be used. It has remained uncertain, however, whether LTZ or CC is more effective in combination with MOS. Therefore, we evaluated the choice of combination either CC or LTZ with MOS and quantified the obtainment of euploid blastocysts for AMA women. Methods This retrospective study was conducted between January 2020 and April 2021. In this study, we stimulated 286 women with MOS, 153 of these women used CC (CC group) and 133 were given LTZ (LTZ group). All women took either 100 mg of CC or 5 mg of LTZ daily for 7 days between MC 3 and MC 9, and 225 IU of recombinant-FSH were administered on MC 3, MC 5, MC 7, and MC 9. The euploid rates were compared between these two groups. Among them, the women who were ≥ 40 years old were divided into two groups, CC-O40 group (n = 61) and LTZ-O40 group (n = 54), and the euploid rates were evaluated. Results: For AMA women, the blastocyst formation rate in the LTZ-O40 group (58.5%) was significantly higher than that in the CC-O40 group (46.6%, P < 0.05). The euploid rate in the LTZ group was 53.4%, which was significantly higher than that in the CC group (38.0%, P < 0.05). The AMA euploid rate in the LTZ-O40 group was 40.5%, which also was significantly higher than that in the CC-O40 group (16.7%, P < 0.05). Conclusions For AMA women, a regimen of LTZ combined with MOS is the most effective ovarian stimulation method for obtaining euploid blastocysts.Keywords
All Related Versions
This publication has 46 references indexed in Scilit:
- Hyaluronan-enriched transfer medium (HETM) can improve the implantation rate in morphologically poor euploid blastocyst transferArchives of Gynecology and Obstetrics, 2023
- Assisted reproductive technology in Japan: A summary report for 2020 by the ethics Committee of the Japan Society of obstetrics and gynecologyReproductive Medicine and Biology, 2023
- Mitochondrial oxygen consumption rate of human embryos declines with maternal ageJournal of Assisted Reproduction and Genetics, 2020
- Clinical strategies for ART treatment of infertile women with advanced maternal ageReproductive Medicine and Biology, 2018
- New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technologyArchives of Gynecology and Obstetrics, 2018
- Blastocyst vs cleavage‐stage embryo transfer: systematic review and meta‐analysis of reproductive outcomesUltrasound in Obstetrics & Gynecology, 2016
- Clinical efficiency of Piezo-ICSI using micropipettes with a wall thickness of 0.625 μmJournal of Assisted Reproduction and Genetics, 2015
- Ongoing and cumulative pregnancy rate after cleavage-stage versus blastocyst-stage embryo transfer using vitrification for cryopreservation: Impact of age on the resultsJournal of Assisted Reproduction and Genetics, 2014
- Clinical outcomes resulting from the transfer of vitrified human embryos using a new device for cryopreservation (plastic blade)Journal of Assisted Reproduction and Genetics, 2010
- Maternal age effect on early human embryonic development and blastocyst formationMolecular Reproduction and Development, 1996